Hepatocellular Carcinoma Consortium

The Hepatocellular Carcinoma (HCC) Laboratory is part of the Mount Sinai Liver cancer Program which leads the HCC Genomic Consortium. The Consortium, led by Josep Llovet, MD, conducts translational research in hepatocellular carcinoma.

HCC International Consortium: Tissue bank collection and genomic studies

  • Todd Golub (Harvard, USA)
  • Vincenzo Mazzaferro (INT, Italy)
  • Lars Zender (U. Hannover, Germany)
  • Jordi Bruix (Barcelona)

Heptromic Consortium, Genomic predictors and oncogenic drivers in hepatocellular carcinoma

  • Manel Esteller (IDIBELL, Spain)
  • Jessica Zucman-Rossi (INSERM, France)
  • Vincenzo Mazzaferro (INT, Italy)
  • Lars Zender (U. Hannover, Germany)
  • Diagenode, Belgium

IDH 1-2 mutations and pathogenesis of intrahepatic cholangiocarcinoma

  • Nabeel Bardeesy (Massachusetts General Hospital)

Gene signatures defining cirrhotic patients at high risk of death

  • Massimo Colombo (Ospedale Maggiore Policlinico, Italy)
  • Nanostring (USA)

Other collaborations:

  • Fibrollamelar HCC Consortium - Seven US and European centers
  • miRNA and HCC - Russell (University of Washington, Seattle)
  • Experimental animal models in HCC - D. Largaespada (Mason University, Minnesota)
  • Oncogenic drivers in hepatoblastoma - C. Armengol (Institut GTiP, Barcelona)
  • Biomarkers of HCC survival after transplantation - J. Rakela (Mayo Clinic, USA)

Contact Us

Melody Tam
Assistant, Liver Cancer Research Program
Tel: 212-659-9614
Fax: 212-849-2574

1425 Madison Avenue
Box 1123
Room 11-70
New York, NY 10029